Lymphoma, Extranodal NK-T-Cell
Recent clinical, regulatory, research and industry developments relating to this disease.
Estimating the global burden of Epstein-Barr virus-related cancers.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- 1 clinical trial expected to report results, the earliest in Q4 2026.
Clinical MilestonesViewHide
- 2026-04-07ClinicalPembrolizumab and Radiotherapy for Previously Untreated Patients With Limited Stage NK/T Cell Lymphoma Who Are Not Eligible to ChemotherapyResults expected Q4 2026
- 2025-12-01ClinicalAllogeneic Stem Cell Transplantation With 3-days Busulfan Plus Fludarabine as Conditioning in Patients With Relapsed or Refractory T-, NK/T-cell LymphomasPrimary completion
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Leading journals1
- Journal of cancer research and clinical oncology1
Leading researchers5
- Burrows SR1
- Doolan DL1
- Meehan MT1
- Miles JJ1
- Wong Y1
Affiliations (unnormalised)5
- Australian Institute of Tropical Health and Medicine1
- Centre for Molecular Therapeutics1
- Centre for Tropical Bioinformatics and Molecular Biology1
- QIMR Berghofer Medical Research Institute1
- The University of Queensland1
Reference
Authoritative identity, definition & identifiers.
An extranodal neoplasm, usually possessing an NK-cell phenotype and associated with EPSTEIN-BARR VIRUS. These lymphomas exhibit a broad morphologic spectrum, frequent necrosis, angioinvasion, and most commonly present in the midfacial region, but also in other extranodal sites.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.